MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype

Accumulating evidence demonstrates that defining molecular subtypes based on objective genetic alterations may permit a more rational, patient-specific approach to molecular targeted therapy across various cancers. The objective of this study was to subtype primary glioblastoma (pGBM) based on Micro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Yan, Wei, Liu, Yanwei, Yang, Pei, Wang, Zheng, You, Yongping, Jiang, Tao
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Clinical Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4484485/
https://ncbi.nlm.nih.gov/pubmed/25869098
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items